A cost-optimized 5-protein panel revolutionizes systemic lupus erythematosus diagnosis
PLOS Computational Biology · 23.07.2026 · 22 (7) · e1014513
DOI: 10.1371/journal.pcbi.1014513 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 23.07.2026. Verfasst von Wenhua Lv und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Blood Proteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Excellent Youth Support plan of Education Department of Heilongjiang Province, Mathematical Tianyuan Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Early diagnosis of systemic lupus erythematosus (SLE) is hindered by a lack of reliable biomarkers. This study sought to identify and evaluate diagnostic plasma protein biomarkers for SLE. We analyzed plasma protein profiles, polygenic risk scores (PRS), and clinical data from 544 SLE cases and 48,036 controls in the UK Biobank. Using LASSO regression, we identified 35 high-confidence SLE-associated proteins and derived a protein risk score (ProtRS). The ProtRS model achieved exceptional diagnostic performance (AUC = 0.91), significantly outperforming models based on PRS or clinical factors alone. Notably, a cost-optimized 5-protein panel (TRIM21, SOD2, KLK3, IL15, ADIPOQ) retained high accuracy (AUC = 0.82) while reducing costs by ~87%. ProtRS also demonstrated the highest population attributable fraction (96.34%), underscoring its dominant contribution to SLE burden. This study establishes a protein-driven framework for early SLE detection, offering tiered diagnostic solutions to balance accuracy and cost. The findings underscore the translational potential of protein biomarkers in bridging theoretical research and clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
ORCID-Profile: Wenhua Lv
Förderung
- National Natural Science Foundation of China
- Excellent Youth Support plan of Education Department of Heilongjiang Province
- Mathematical Tianyuan Fund of the National Natural Science Foundation of China
- Fundamental Research Funds for the Provincial Universities in Heilongjiang province, China
- Marshal Initiative Funding
- Fundamental Research Funds for the Provincial Universities in Heilongjiang Province
Zitieren
APA
Lv, W., Shang, Z., Sun, C., Zou, Y., Wei, S., Chen, H., Tao, J., Tian, H., Dong, Y., Zhang, C., Zhang, M., Lv, H., & Jiang, Y. (2026). A cost-optimized 5-protein panel revolutionizes systemic lupus erythematosus diagnosis. PLOS Computational Biology, 22(7), e1014513. https://doi.org/10.1371/journal.pcbi.1014513
Vancouver
Lv W, Shang Z, Sun C, Zou Y, Wei S, Chen H, et al. A cost-optimized 5-protein panel revolutionizes systemic lupus erythematosus diagnosis. PLOS Computational Biology. 2026;22(7):e1014513. doi:10.1371/journal.pcbi.1014513
BibTeX
@article{Lv2026,
author = {Lv, Wenhua and Shang, Zhenwei and Sun, Chen and Zou, Yuping and Wei, Siyu and Chen, Haiyan and Tao, Junxian and Tian, Hongsheng and Dong, Yu and Zhang, Chen and Zhang, Mingming and Lv, Hongchao and Jiang, Yongshuai},
title = {A cost-optimized 5-protein panel revolutionizes systemic lupus erythematosus diagnosis},
journal = {PLOS Computational Biology},
year = {2026},
volume = {22},
number = {7},
pages = {e1014513},
doi = {10.1371/journal.pcbi.1014513}
}
EUVIMED